Toll-like receptors in natural killer cells and their application for immunotherapy

Cited 64 time in scopus
Metadata Downloads

Full metadata record

DC FieldValueLanguage
dc.contributor.authorJi Yoon Noh-
dc.contributor.authorSuk Ran Yoon-
dc.contributor.authorTae-Don Kim-
dc.contributor.authorIn Pyo Choi-
dc.contributor.authorHaiyoung Jung-
dc.date.accessioned2020-02-07T16:31:07Z-
dc.date.available2020-02-07T16:31:07Z-
dc.date.issued2020-
dc.identifier.issn2314-8861-
dc.identifier.uri10.1155/2020/2045860ko
dc.identifier.urihttps://oak.kribb.re.kr/handle/201005/19303-
dc.description.abstractInnate immunity represents the first barrier for host defense against microbial infection. Toll-like receptors (TLRs) are the most well-defined PRRs with respect to PAMP recognition and induction of innate immune responses. They recognize pathogen-associated molecular patterns (PAMPs) and trigger innate immune responses by inducing inflammatory cytokines, chemokines, antigen-presenting molecules, and costimulatory molecules. TLRs are expressed either on the cell surface or within endosomes of innate immune cells. NK cells are one of the innate immune cells and also express TLRs to recognize or respond to PAMPs. TLRs in NK cells induce the innate immune responses against bacterial and viral infections via inducing NK cytotoxicity and cytokine production. In this review, we will discuss the expression and cellular function of TLRs in NK cells and also introduce some therapeutic applications of TLR agonists for NK cell-mediated immunotherapy.-
dc.publisherHindawi Ltd-
dc.titleToll-like receptors in natural killer cells and their application for immunotherapy-
dc.title.alternativeToll-like receptors in natural killer cells and their application for immunotherapy-
dc.typeArticle-
dc.citation.titleJournal of Immunology Research-
dc.citation.number0-
dc.citation.endPage2045860-
dc.citation.startPage2045860-
dc.citation.volume2020-
dc.contributor.affiliatedAuthorJi Yoon Noh-
dc.contributor.affiliatedAuthorSuk Ran Yoon-
dc.contributor.affiliatedAuthorTae-Don Kim-
dc.contributor.affiliatedAuthorIn Pyo Choi-
dc.contributor.affiliatedAuthorHaiyoung Jung-
dc.contributor.alternativeName노지윤-
dc.contributor.alternativeName윤석란-
dc.contributor.alternativeName김태돈-
dc.contributor.alternativeName최인표-
dc.contributor.alternativeName정해용-
dc.identifier.bibliographicCitationJournal of Immunology Research, vol. 2020, pp. 2045860-2045860-
dc.identifier.doi10.1155/2020/2045860-
dc.description.journalClassY-
Appears in Collections:
Aging Convergence Research Center > 1. Journal Articles
Division of A.I. & Biomedical Research > Immunotherapy Research Center > 1. Journal Articles
Files in This Item:

Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.